Quick answer: VIP (vasoactive intestinal peptide) is a naturally occurring 28-residue neuropeptide in the secretin/glucagon family. It acts mainly through the class B receptors VPAC1 and VPAC2, which raise intracellular cAMP, and it is studied in cell and animal models of smooth muscle, immune-cell and neuronal signaling. It is a laboratory research compound only. This explainer covers the name, structure, receptors, research themes, how VIP compares with related peptides, and what to check on a certificate of analysis.
Where the name VIP comes from
VIP stands for vasoactive intestinal peptide, sometimes written vasoactive intestinal polypeptide. The name is a description of how it was found. In 1970, Said and Mutt purified a 28-amino-acid factor from porcine small intestine that relaxed vascular smooth muscle in animal preparations, and they called it vasoactive because of that effect and intestinal because of where it came from. Later work showed that the same peptide is widely distributed in neurons of the central and peripheral nervous systems, so the “intestinal” label undersells it.
Unlike some catalog names, this one is informative. VIP is a natural endogenous neuropeptide, and the synthetic material used in laboratories reproduces the native sequence.
Structure: 28 residues in the secretin/glucagon family
VIP is a linear peptide with the sequence His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn, with an amidated C-terminus. Its mass is roughly 3.3 kDa. It belongs to a structurally related group that includes secretin, glucagon, GHRH, GIP and PACAP. Members of this family share a helical tendency in the middle and C-terminal region and a histidine at position 1, features that matter for receptor recognition.
In solution, VIP is largely unstructured, and it is thought to adopt a helical conformation when it meets a membrane or its receptor. That is a common pattern across the family and is one reason receptor-binding studies use cells or membrane preparations instead of simple buffers. If sequence notation is new to you, understanding amino acid sequences is a useful primer, and what are research peptides covers the wider category.
Receptors: VPAC1, VPAC2 and the cAMP pathway
VIP signals mainly through two class B G protein-coupled receptors, VPAC1 and VPAC2. Both couple predominantly to Gs, which activates adenylyl cyclase and raises intracellular cyclic AMP. Rising cAMP activates protein kinase A, which phosphorylates downstream targets and transcription factors such as CREB. Depending on the cell type, coupling to phospholipase C and other effectors has also been described.
VPAC1 is abundant in tissues such as lung, liver and intestinal epithelium in rodent and cell-line work, while VPAC2 shows a more restricted pattern that includes parts of the brain and smooth muscle. Pharmacology reviews describe VIP as binding both with high affinity. The related peptide PACAP binds the VPAC receptors too and also has its own receptor, PAC1, so comparing the two peptides in an assay requires care about which receptor population is present. For wider context on how peptide hormones act through this receptor class, see incretin receptors explained, which describes a different but mechanistically comparable class B system.
What the preclinical literature examines
Everything below is in-vitro, cell-based or animal-model work. None of it is a statement about use in people.
Smooth muscle and vascular preparations. The original isolation work and many later organ-bath studies examined relaxation of isolated smooth muscle tissue.
Immune-cell signaling. Reviews of the literature describe VIP as a neuropeptide that interacts with macrophages, dendritic cells and T cells in culture, and report effects on cytokine production in those systems. Delgado and colleagues organized much of this work.
Neuronal and circadian models. VIP-expressing neurons are studied in rodent suprachiasmatic nucleus preparations, where VPAC2 signaling is linked to synchronizing cellular clocks.
Epithelial and secretory models. Cell-line and tissue work has looked at cAMP-driven ion and fluid transport.
A caution on interpretation: VIP acts on cells that also express PACAP receptors, peptidases degrade it quickly, and results depend heavily on the cell line and preparation. Read the primary papers rather than summaries.
VIP compared with related peptides
The table gives descriptors only, not performance claims.
| Peptide | Length | Main receptors | Typical research context |
|---|---|---|---|
| VIP | 28 residues | VPAC1, VPAC2 | cAMP signaling, smooth muscle, immune-cell and neuronal models |
| PACAP-38 | 38 residues | PAC1, VPAC1, VPAC2 | Neuropeptide signaling, PAC1-specific assays |
| Secretin | 27 residues | Secretin receptor | Pancreatic and epithelial secretion models |
| Glucagon | 29 residues | Glucagon receptor | Class B receptor and hepatic cell models |
Stability and handling of the lyophilized powder
VIP is supplied as a freeze-dried powder. In solution it is sensitive to enzymatic cleavage, and the methionine at position 17 can oxidize, so general practice is to keep sealed vials cold, dry and away from light, limit temperature cycling, and write down the date a vial is first opened. Let a cold vial reach room temperature before opening to reduce condensation. See storing research peptides and what is lyophilization for the basics. Planning solution volumes for an experiment is best done with the reconstitution calculator.
What to check on a VIP certificate of analysis
At 28 residues, synthesis can leave truncated sequences and oxidized variants, so documentation matters more than for short peptides.
HPLC purity with the chromatogram, not only a percentage. Look at minor peaks and at how they were integrated. Understanding HPLC purity explains the numbers.
Identity confirmation. As general buying guidance, ask what method confirms a mass near 3.3 kDa, and see it in the report. HPLC versus mass spectrometry explains how the two methods differ.
Lot reference and date that match the vial, and the name of the testing laboratory.
Stated fill amount and whether it describes total powder or net peptide.
Walk through each section in how to read a COA. V8 Peptides sells its products for laboratory research use only and publishes certificates of analysis for tested lots on the COA page. VIP, a 10 mg research vial, is coming soon to the V8 catalog, and the listing will live at /products/vip. Browse current items in the shop.
Common misunderstandings
“VIP is only a gut peptide.” It is widely expressed in neurons and was named for where it was first isolated.
“VIP and PACAP are interchangeable.” They share VPAC receptors, but PACAP also has PAC1 and a different length.
“Cell results carry over to organisms.” They do not automatically, and this article makes no such claim.
Frequently asked questions
What is VIP?
Vasoactive intestinal peptide, a 28-residue neuropeptide of the secretin/glucagon family that signals mainly through the VPAC1 and VPAC2 receptors and the cAMP pathway.
How many amino acids does VIP have?
Twenty-eight, with an amidated C-terminus. The sequence is His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2.
Which receptors does VIP act on?
VPAC1 and VPAC2, both class B G protein-coupled receptors. VIP also shows lower-affinity interaction with PAC1 in pharmacology studies.
How is VIP related to PACAP?
PACAP is a close paralog that shares the VPAC receptors and a similar N-terminal region. PACAP additionally has a high-affinity receptor of its own, PAC1.
Why is VIP described as vasoactive?
It was first isolated in 1970 from intestinal tissue as a factor that relaxed vascular smooth muscle in animal preparations, which gave the peptide its name.
Is VIP approved for human use?
No. V8 Peptides sells VIP for laboratory research use only, and it is not intended for human or animal consumption.
Is VIP available now?
Check the product page for current status.
Why is VIP hard to work with in vitro?
It is cleared quickly by peptidases in biological media, so experimental design usually accounts for short stability in culture or tissue preparations.
What should I check on a VIP COA?
An HPLC chromatogram, an identity method confirming the expected mass of about 3.3 kDa, a lot reference matching the vial, a test date and a named laboratory.
How should lyophilized VIP be stored?
Sealed, cold, dry and protected from light, with temperature cycling avoided and the first-opened date recorded.
References
- Said SI, Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science. 1970;169(3951):1217-1218. PMID: 5450698.
- Delgado M, Pozo D, Ganea D. The significance of vasoactive intestinal peptide in immunomodulation. Pharmacol Rev. 2004;56(2):249-290. PMID: 15169929.
- Vaudry D, Falluel-Morel A, Bourgault S, et al. Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev. 2009;61(3):283-357. PMID: 19805477.
- Harmar AJ, Fahrenkrug J, Gozes I, et al. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1. Br J Pharmacol. 2012;166(1):4-17. PMID: 22289055.
- Couvineau A, Laburthe M. VPAC receptors: structure, molecular pharmacology and interaction with accessory proteins. Br J Pharmacol. 2012;166(1):42-50. PMID: 21951273.
All V8 Peptides products are sold for laboratory research use only. They are not drugs, foods, or cosmetics and are not intended for human or animal consumption.
